Developer docs
API playgroundTry for free, no card

Search company profiles

Mayoly

Full company profile

uuid004v1vn

Namestring
Mayoly
Legal namestring
MAYOLY
Websiteurl
mayoly.com
Company typeenum
Private
Founded yearint
1912
Descriptiontext

Mayoly is a French, family-owned and independent pharmaceutical laboratory headquartered in Rueil-Malmaison, Île-de-France, operating for more than 100 years across five segments: Consumer Healthcare (notably Probiolog probiotics and OTC products), Pharma (Mayoly-Spindler brand spanning gastroenterology, ORL, and rheumatology), Dermocosmetics (Topicrem brand for sensitive skin of babies, children, and adults), Diagnostic (Mayoly Diagnostic and Kibion systems for Helicobacter pylori testing), and Production (contract and captive manufacturing). The company serves a multi-tier customer base that includes end consumers and patients buying through pharmacies, healthcare professionals such as pharmacists, dermatologists, and gastroenterologists who recommend or prescribe its products, medical laboratories using its diagnostic platforms, and B2B partners requiring GMP-compliant manufacturing capacity.

Its core technology combines pharmaceutical manufacturing at six industrial sites (five in France - three in the Paris region, one in Dreux, one in L'Isle-sur-la-Sorgue - and one international), dermo-cosmetic formulation expertise built around the Topicrem range created in 1994, and proprietary diagnostic instrumentation for H. pylori detection and eradication control acquired through the 2016 Kibion acquisition and formalized as Mayoly Diagnostic in 2019. More than 85% of products sold worldwide are manufactured at its French sites, and nearly 100% of the Topicrem range is produced in-house.

Mayoly monetizes primarily through one-time sales of prescription and OTC pharmaceuticals, dermo-cosmetic products, and probiotic food supplements via pharmacy distribution channels in more than 100 countries, supplemented by diagnostic system and consumable sales and contract manufacturing services. Go-to-market is sales-led, anchored by pharmaceutical sales representatives (délégués pharmaceutiques) engaging pharmacies and healthcare professionals, with parallel international distribution through local subsidiaries and partner networks and a growing digital and pharmacy e-commerce presence for Topicrem.

Short descriptiontext

Mayoly is a French, family-owned pharmaceutical laboratory with over 100 years of heritage, operating across gastroenterology, dermocosmetics (Topicrem), probiotics (Probiolog), and Helicobacter pylori diagnostics (Kibion, Mayoly Diagnostic), serving patients, healthcare professionals, and consumers in 100+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersRueil-Malmaison, Île-de-France, France
HQ citystring
Rueil-Malmaison, Île-de-France
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
gastroenterology pharmaceuticals, dermo-cosmetic products, pharmaceutical manufacturing, probiotic supplements, medical diagnostic systems
Industry3 codes
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAF
Probiotics & Digestive Health Supplements
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code4 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
  • Soap and Cleaning Compound Manufacturing32561
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code4 codes
  • Pharmaceutical Preparations2834
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Services-Medical Laboratories8071
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Pharmaceutical and Dermo-Cosmetic Products
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model6 records
1Pharmaceutical products
TypeOne Time License
Description

Core pharmaceutical business focused on gastroenterology, ORL, and rheumatology with production from French industrial sites in Chatou and Dammarie-les-Lys

mayoly.com
2Consumer Healthcare - OTC and supplements
TypeOne Time License
Description

Over-the-counter medications and supplements including Probiolog (probiotics) and other consumer health products sold in pharmacies

mayoly.com
3Dermocosmetics - Topicrem brand
TypeOne Time License
Description

Dermo-cosmetic products under Topicrem brand for sensitive skin, present in more than 40 countries

mayoly.com
4Pharma - Mayoly-Spindler
TypeOne Time License
Description

General medicine products with expertise in ORL, rheumatology, and gastroenterology

mayoly.com
5Diagnostic - Mayoly Diagnostic
TypeOne Time License
Description

Diagnostic systems and consumables for Helicobacter pylori testing and eradication control

mayoly.com
6Contract manufacturing
TypeProfessional Services
Description

Industrial production services with 5.3M EUR investment in 2022 for maintenance and decarbonation

mayoly.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Topicrem
Description

Dermo-cosmetic brand created by Jean-Gilles Vernin in 1994 for sensitive skin care products for babies, children and adults. Present in more than 40 countries.

mayoly.com
+4 more records
Core offering1 text field

Mayoly is a French, family-owned pharmaceutical laboratory that develops, manufactures, and commercializes pharmaceutical products focused on gastroenterology, ORL, and rheumatology, along with dermo-cosmetic skincare products (Topicrem) for sensitive skin, probiotic supplements (Probiolog), and H. pylori diagnostic systems (Mayoly Diagnostic/Kibion). The company operates 6 industrial sites that manufacture more than 85% of its products and distributes through pharmacy networks in 100+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 41% reduction in scopes 1 and 2 emissions achieved in 2025 vs 2019 baseline, on track for 50% reduction by 2030
+2 more records
Product overview1 text field

Mayoly is a French, family-owned, independent pharmaceutical laboratory with over 100 years of expertise. The company operates across four main segments: Pharma (centered on gastroenterology, ORL, and rheumatology), Dermocosmetics (via the Topicrem brand), Diagnostic (via Mayoly Diagnostic and Kibion), and Production (manufacturing with 6 industrial sites). The portfolio includes prescription and OTC pharmaceuticals, dermo-cosmetic skincare products, probiotic supplements (Probiolog), and diagnostic solutions for Helicobacter pylori. The company employs over 2,200 collaborators across more than 100 countries.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Pierre-Louis Attwell (IMOCA RESILIENT)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Mayoly has partnered with skipper Pierre-Louis Attwell and his IMOCA RESILIENT sailing vessel for the Vendée Globe 2028 race. This partnership, starting from 2016, embodies shared values of entrepreneurship, ambition, authenticity and challenge. The partnership represents Mayoly's commitment to pushing boundaries and transforming challenges into opportunities.

vendee-globe2028.mayoly.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

Mayoly acquired Kibion in 2016, an international player in functional exploration instruments and tests for Helicobacter pylori diagnosis and eradication control. This acquisition enabled Mayoly to create Mayoly Diagnostic in 2019 as a strategic pillar for the development of the laboratories.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global dermatology-focused pharmaceutical and dermo-cosmetic company; directly comparable to Mayoly's Topicrem franchise in sensitive-skin prescription and OTC dermatology, with a larger but adjacent therapeutic-area focus.

TypeDirect peer
Description

Mid-sized European specialty pharmaceutical company with a mix of Rx, OTC, and consumer healthcare brands focused on a small number of therapeutic areas; similar scale, specialty-pharma profile, and prior M&A activity (e.g., Perrigo acquisition) make HRA Pharma a comparable peer.

3BioGaia
TypeDirect peer
Description

Swedish probiotic and digestive-health specialist selling through pharmacy and HCP channels globally; directly comparable to Mayoly's Probiolog consumer healthcare probiotics franchise in terms of brand positioning, channel, and category.

4Bayer Consumer Health
TypeBroad incumbent
Description

Broad incumbent in OTC and consumer healthcare with significant pharmacy distribution and international footprint; directly competes with Mayoly's consumer healthcare and probiotic supplements portfolio, though from a much larger and more diversified base.

TypeDirect peer
Description

French dermo-cosmetics specialist sold through pharmacy channels globally; highly comparable to Topicrem in pharmacy-distributed sensitive-skin skincare positioning, channel strategy, and brand-portfolio structure.

TypeBroad incumbent
Description

Large French multinational pharmaceutical company with overlapping franchises in gastroenterology, consumer healthcare (OTC, probiotics), and dermatology; competes for the same HCP and pharmacy channel relationships but at materially greater scale and breadth.

TypeBroad incumbent
Description

Privately held French pharmaceutical laboratory with a broader therapeutic-area portfolio and significant international footprint; comparable French private-pharma heritage, governance style, and scale put it in the same peer set even though its portfolio is wider than Mayoly's gastroenterology/dermatology focus.

TypeDirect peer
Description

French family-owned pharmaceutical and dermo-cosmetics group with overlapping activities in dermatology, gastroenterology-adjacent pharma, and in-house manufacturing; comparable scale, ownership structure, and brand-led dermo positioning make it the closest like-for-like peer to Mayoly.

TypeEmerging player
Description

L'Oréal-owned dermatological skincare brand distributed primarily through pharmacy channels globally; competes head-to-head with Topicrem in sensitive-skin skincare but operates as a brand within a much larger cosmetics platform.

10Cooper Consumer Health (formerly Omega Pharma)
TypeDirect peer
Description

European mid-size consumer healthcare platform with broad OTC portfolio distributed primarily via pharmacy and drugstore channels; comparable in mid-size European OTC/consumer healthcare positioning, channel structure, and recent PE-backed strategic profile.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mayoly

Pharmaceutical and Dermo-Cosmetic Productsmayoly.com

Mayoly is a French, family-owned pharmaceutical laboratory with over 100 years of heritage, operating across gastroenterology, dermocosmetics (Topicrem), probiotics (Probiolog), and Helicobacter pylori diagnostics (Kibion, Mayoly Diagnostic), serving patients, healthcare professionals, and consumers in 100+ countries.

What Mayoly does

Mayoly is a French, family-owned and independent pharmaceutical laboratory headquartered in Rueil-Malmaison, Île-de-France, operating for more than 100 years across five segments: Consumer Healthcare (notably Probiolog probiotics and OTC products), Pharma (Mayoly-Spindler brand spanning gastroenterology, ORL, and rheumatology), Dermocosmetics (Topicrem brand for sensitive skin of babies, children, and adults), Diagnostic (Mayoly Diagnostic and Kibion systems for Helicobacter pylori testing), and Production (contract and captive manufacturing). The company serves a multi-tier customer base that includes end consumers and patients buying through pharmacies, healthcare professionals such as pharmacists, dermatologists, and gastroenterologists who recommend or prescribe its products, medical laboratories using its diagnostic platforms, and B2B partners requiring GMP-compliant manufacturing capacity.

Its core technology combines pharmaceutical manufacturing at six industrial sites (five in France - three in the Paris region, one in Dreux, one in L'Isle-sur-la-Sorgue - and one international), dermo-cosmetic formulation expertise built around the Topicrem range created in 1994, and proprietary diagnostic instrumentation for H. pylori detection and eradication control acquired through the 2016 Kibion acquisition and formalized as Mayoly Diagnostic in 2019. More than 85% of products sold worldwide are manufactured at its French sites, and nearly 100% of the Topicrem range is produced in-house.

Mayoly monetizes primarily through one-time sales of prescription and OTC pharmaceuticals, dermo-cosmetic products, and probiotic food supplements via pharmacy distribution channels in more than 100 countries, supplemented by diagnostic system and consumable sales and contract manufacturing services. Go-to-market is sales-led, anchored by pharmaceutical sales representatives (délégués pharmaceutiques) engaging pharmacies and healthcare professionals, with parallel international distribution through local subsidiaries and partner networks and a growing digital and pharmacy e-commerce presence for Topicrem.

Mayoly firmographics

Firmographics
Name
Mayoly
Legal name
MAYOLY
Website
https://mayoly.com
Company type
Private
Founded year
1912
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Mayoly is a French, family-owned pharmaceutical laboratory with over 100 years of heritage, operating across gastroenterology, dermocosmetics (Topicrem), probiotics (Probiolog), and Helicobacter pylori diagnostics (Kibion, Mayoly Diagnostic), serving patients, healthcare professionals, and consumers in 100+ countries.
Ownership category
akta.pro rank

Mayoly industry classification

Industry
Product category
Pharmaceutical and Dermo-Cosmetic Products
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Soap and Cleaning Compound Manufacturing (32561), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844), Services-Medical Laboratories (8071), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAF
Probiotics & Digestive Health Supplements
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Gastroenterology pharmaceuticals
  • Dermo-cosmetic products
  • Pharmaceutical manufacturing
  • Probiotic supplements
  • Medical diagnostic systems

Where Mayoly is headquartered

Location

Headquarters

HQ city
Rueil-Malmaison, Île-de-France
HQ country
France
HQ region
Europe

Offices6 records

Markets served

Mayoly business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical products: Core pharmaceutical business focused on gastroenterology, ORL, and rheumatology with production from French industrial sites in Chatou and Dammarie-les-Lys
  2. Consumer Healthcare - OTC and supplements: Over-the-counter medications and supplements including Probiolog (probiotics) and other consumer health products sold in pharmacies
  3. Dermocosmetics - Topicrem brand: Dermo-cosmetic products under Topicrem brand for sensitive skin, present in more than 40 countries
  4. Pharma - Mayoly-Spindler: General medicine products with expertise in ORL, rheumatology, and gastroenterology
  5. Diagnostic - Mayoly Diagnostic: Diagnostic systems and consumables for Helicobacter pylori testing and eradication control
  6. Contract manufacturing: Industrial production services with 5.3M EUR investment in 2022 for maintenance and decarbonation

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Mayoly product offering

Product offering

Core offering

Mayoly is a French, family-owned pharmaceutical laboratory that develops, manufactures, and commercializes pharmaceutical products focused on gastroenterology, ORL, and rheumatology, along with dermo-cosmetic skincare products (Topicrem) for sensitive skin, probiotic supplements (Probiolog), and H. pylori diagnostic systems (Mayoly Diagnostic/Kibion). The company operates 6 industrial sites that manufacture more than 85% of its products and distributes through pharmacy networks in 100+ countries.

Product overview

Mayoly is a French, family-owned, independent pharmaceutical laboratory with over 100 years of expertise. The company operates across four main segments: Pharma (centered on gastroenterology, ORL, and rheumatology), Dermocosmetics (via the Topicrem brand), Diagnostic (via Mayoly Diagnostic and Kibion), and Production (manufacturing with 6 industrial sites). The portfolio includes prescription and OTC pharmaceuticals, dermo-cosmetic skincare products, probiotic supplements (Probiolog), and diagnostic solutions for Helicobacter pylori. The company employs over 2,200 collaborators across more than 100 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Topicrem: Dermo-cosmetic brand created by Jean-Gilles Vernin in 1994 for sensitive skin care products for babies, children and adults. Present in more than 40 countries.
  • Kibion
  • Mayoly Diagnostic
  • Mayoly-Spindler
  • Probiolog

Quantifiable outcome

  • 41% reduction in scopes 1 and 2 emissions achieved in 2025 vs 2019 baseline, on track for 50% reduction by 2030
  • +2 more outcomes

Companies that use Mayoly

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Mayoly technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Mayoly partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor and core.

  • Pierre-Louis Attwell (IMOCA RESILIENT)minorStrategic or Co-development Partner · 1 January 2024Mayoly has partnered with skipper Pierre-Louis Attwell and his IMOCA RESILIENT sailing vessel for the Vendée Globe 2028 race. This partnership, starting from 2016, embodies shared values of entrepreneurship, ambition, authenticity and challenge. The partnership represents Mayoly's commitment to pushing boundaries and transforming challenges into opportunities.
  • KibioncoreStrategic or Co-development Partner · 1 January 2016Mayoly acquired Kibion in 2016, an international player in functional exploration instruments and tests for Helicobacter pylori diagnosis and eradication control. This acquisition enabled Mayoly to create Mayoly Diagnostic in 2019 as a strategic pillar for the development of the laboratories.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Mayoly competitors and assessment

Company assessment

Direct peers

  • Galderma: Global dermatology-focused pharmaceutical and dermo-cosmetic company; directly comparable to Mayoly's Topicrem franchise in sensitive-skin prescription and OTC dermatology, with a larger but adjacent therapeutic-area focus.
  • HRA Pharma: Mid-sized European specialty pharmaceutical company with a mix of Rx, OTC, and consumer healthcare brands focused on a small number of therapeutic areas; similar scale, specialty-pharma profile, and prior M&A activity (e.g., Perrigo acquisition) make HRA Pharma a comparable peer.
  • BioGaia: Swedish probiotic and digestive-health specialist selling through pharmacy and HCP channels globally; directly comparable to Mayoly's Probiolog consumer healthcare probiotics franchise in terms of brand positioning, channel, and category.
  • Uriage (Laboratoires Dermatologiques d'Uriage): French dermo-cosmetics specialist sold through pharmacy channels globally; highly comparable to Topicrem in pharmacy-distributed sensitive-skin skincare positioning, channel strategy, and brand-portfolio structure.
  • Pierre Fabre: French family-owned pharmaceutical and dermo-cosmetics group with overlapping activities in dermatology, gastroenterology-adjacent pharma, and in-house manufacturing; comparable scale, ownership structure, and brand-led dermo positioning make it the closest like-for-like peer to Mayoly.
  • Cooper Consumer Health (formerly Omega Pharma): European mid-size consumer healthcare platform with broad OTC portfolio distributed primarily via pharmacy and drugstore channels; comparable in mid-size European OTC/consumer healthcare positioning, channel structure, and recent PE-backed strategic profile.

Broad incumbents

  • Bayer Consumer Health: Broad incumbent in OTC and consumer healthcare with significant pharmacy distribution and international footprint; directly competes with Mayoly's consumer healthcare and probiotic supplements portfolio, though from a much larger and more diversified base.
  • Sanofi: Large French multinational pharmaceutical company with overlapping franchises in gastroenterology, consumer healthcare (OTC, probiotics), and dermatology; competes for the same HCP and pharmacy channel relationships but at materially greater scale and breadth.
  • Servier: Privately held French pharmaceutical laboratory with a broader therapeutic-area portfolio and significant international footprint; comparable French private-pharma heritage, governance style, and scale put it in the same peer set even though its portfolio is wider than Mayoly's gastroenterology/dermatology focus.

Emerging players

  • La Roche-Posay (L'Oréal Dermatological Beauty): L'Oréal-owned dermatological skincare brand distributed primarily through pharmacy channels globally; competes head-to-head with Topicrem in sensitive-skin skincare but operates as a brand within a much larger cosmetics platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Mayoly social profiles

Digital presence

Mayoly financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mayoly leadership team

Management profile

Number of profiles

Profiles2 records

Mayoly subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Mayoly funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mayoly M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mayoly

What does Mayoly do?

Mayoly is a French, family-owned pharmaceutical laboratory that develops, manufactures, and commercializes pharmaceutical products focused on gastroenterology, ORL, and rheumatology, along with dermo-cosmetic skincare products (Topicrem) for sensitive skin, probiotic supplements (Probiolog), and H. pylori diagnostic systems (Mayoly Diagnostic/Kibion). The company operates 6 industrial sites that manufacture more than 85% of its products and distributes through pharmacy networks in 100+ countries.

Is Mayoly a public or private company?

Mayoly is a private company. It is classified as family owned and is currently operating.

When was Mayoly founded?

Mayoly was founded in 1912. It employs 1,001 to 5,000 people.

Where is Mayoly based?

Mayoly is headquartered in Rueil-Malmaison, Île-de-France, France, in the Europe region.

How does Mayoly make money?

Six revenue lines are on record. Pharmaceutical products are the primary driver. The others are consumer Healthcare - OTC and supplements, dermocosmetics - Topicrem brand, pharma - Mayoly-Spindler, diagnostic - Mayoly Diagnostic and contract manufacturing.

Who are Mayoly's main competitors?

Direct peers on record are Galderma, HRA Pharma, BioGaia, Uriage (Laboratoires Dermatologiques d'Uriage), Pierre Fabre and Cooper Consumer Health (formerly Omega Pharma). Broad incumbents are Bayer Consumer Health, Sanofi and Servier. La Roche-Posay (L'Oréal Dermatological Beauty) is listed as an emerging player.

Does Mayoly have an API?

No public API is recorded for Mayoly.

What industry is Mayoly in?

Mayoly's product category is Pharmaceutical and Dermo-Cosmetic Products. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales